A cost-effectiveness analysis of modafinil therapy for psychostimulant dependence
Introduction and Aims. To examine the cost-effectiveness of modafinil (200 mg daily) plus counselling compared with placebo for the treatment of psychostimulant dependence. Design and Methods. Cost and outcome data were collected alongside two randomised
|Collections||ANU Research Publications|
|Source:||Drug and Alcohol Review|
|01_Shearer_A_cost-effectiveness_analysis_2010.pdf||439.8 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.